LinkOPH

Allergan has filed a lawsuit in the U.S. District Court against Valeant Pharmaceuticals, Pershing Square Capital Management, and its principal, William A. Ackman, citing violations to federal securities laws prohibiting insider trading, engagement in fraudulent practices and failure to disclose legally required information.The complaint alleges that between February and April 2014, Pershing Square purchased Allergan stock and securities valued at more than $3.2 billion from unknowing Allergan stockholders, with full understanding of Valeant’s non-public takeover intensions.

Read more →

After a long wait, CMS has confirmed Oct. 1, 2015 as the implementation date for the use of ICD-10 codes. Controversy has surrounded the new coding system for its higher level of detail and the delay in setting a date for its implementation.

Read more →

Kala Pharmaceuticals announced the initiation of a phase 2 clinical trial of KP-121, its loteprednol etabonate mucus penetrating particle platform, in patients with retinal vein occlusion and diabetic macular edema.The company is also launching a phase…

Read more →

As with eye surgeons, not all optometrists are created equally. It’s a broad but true generalization that younger ODs are better trained and equipped to step into a busy ophthalmic practice. Sparky doctors, both in intelligence and energy, can see more patients than dull docs.Recruiting a high-quality optometrist is generally much easier than finding a top-flight ophthalmologist. It pays to aim for a higher-quality doctor; small increments in compensation can yield large benefits in productivity and ease of management. Here’s a sample ad with all the right buzz words

Read (Read more...)

The FDA announced it is making access to its adverse drug reaction reports easier to obtain, with open access to the public. In a press release, Taha Kass-Hout, MD, MS, chief health informatics officer at FDA, said that the information previously diffi…

Read more →